First Header Logo Second Header Logo

Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.

Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004 Mar 15; 64(6):2070-5.

View in: PubMed